Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dinesh Patel

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Haematologica|August 3, 2019
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cellsHarish Kumar, Sourav Chattopadhyay, Nabanita Das, et al.
PLOS Global Public Health|March 29, 2023
Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020-February 2021Alicia Dunajcik, Kambria Haire, Jennifer D Thomas, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Pharmacology Research & Perspectives|August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancerKrishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
Haematologica|August 3, 2019
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cellsHarish Kumar, Sourav Chattopadhyay, Nabanita Das, et al.
PLOS Global Public Health|March 29, 2023
Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020-February 2021Alicia Dunajcik, Kambria Haire, Jennifer D Thomas, et al.
Pageof 6